LifeStance Health Group, Inc. 2026 Q3 - Results - Earnings Call Presentation
Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $16
Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $17
Loading...